.Sanofi has actually brought in an overdue access to the radioligand party, paying for one hundred t...
.After F2G's 1st try to receive a new training class of antifungal to market was actually derailed b...
.Moderna has actually vowed to reduce R&D costs by $1.1 billion through 2027. The selection to sh...
.Simply four months after Sanofi wager $80 million in beforehand money on Fulcrum Therapies' losmapi...
.Cancer business Oncternal Therapeutics is folding all its own medical tests and giving up personnel...
.Roche is storing out chances that its injectable weight problems possibility could eventually displ...
.Novo Nordisk has elevated the cover on a phase 1 trial of its own dental amylin as well as GLP-1 re...
.Merely a couple of quick full weeks after gaining an FDA Fast Track tag for its own investigational...
.Soon after a good data decrease for Eli Lilly's efsitora alfa, the Indianapolis-based provider is a...
.BridgeBio Pharma is lowering its gene therapy budget and pulling back coming from the method after ...